Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1107284

Assessment of Illumina® Human mtDNA Genome assay: workflow evaluation with development of analysis and interpretation guidelines


Sukser, Viktorija; Rokić, Filip; Barbarić, Lucija; Korolija, Marina
Assessment of Illumina® Human mtDNA Genome assay: workflow evaluation with development of analysis and interpretation guidelines // International journal of legal medicine, 135 (2021), 1161-1178 doi:10.1007/s00414-021-02508-z (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1107284 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Assessment of Illumina® Human mtDNA Genome assay: workflow evaluation with development of analysis and interpretation guidelines

Autori
Sukser, Viktorija ; Rokić, Filip ; Barbarić, Lucija ; Korolija, Marina

Izvornik
International journal of legal medicine (0937-9827) 135 (2021); 1161-1178

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
MiSeq ; mitochondrial DNA ; Nextera XT ; evaluation ; analysis thresholds

Sažetak
Mitochondrial DNA (mtDNA) is a small but significant part of the human genome, whose applicability potential has gradually increased with the advent of massively parallel sequencing (MPS) technology. Knowledge of the particular workflow, equipment and reagents used, along with extensive usage of negative controls to monitor all preparation steps constitute the prerequisites for confident reporting of results. In this study, we performed assessment of Illumina® Human mtDNA Genome assay on MiSeq FGx TM instrument. Through analysis of several types of negative controls, as well as mtDNA positive controls, we established thresholds for data analysis and interpretation, consisting of several components: minimum read depth (220 reads), minimum quality score (41), percentage of minor allele sufficient for analysis (3.0%), percentage of minor allele sufficient for interpretation (6.0%), and percentage of major allele sufficient for homoplasmic variant call (97.0%). Based on these criteria, we defined internal guidelines for analysis and interpretation of mtDNA results obtained by MPS. Our study shows that the whole mtDNA assay on MiSeq FGx TM produces repeatable and reproducible results, independent of analyst, which are also concordant with Sanger-type sequencing results for mtDNA control region, as well as with MPS results produced by NextSeq®. Overall, established thresholds and interpretation guidelines were successfully applied for sequencing of complete mitochondrial genomes from high-quality samples. The underlying principles and proposed methodology on definition of internal laboratory guidelines for analysis and interpretation of MPS results may be applicable to similar MPS workflows, primarily in forensic genetics and molecular diagnostics.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove:
Institut "Ruđer Bošković", Zagreb,
Centar za forenzična ispitivanja, istraživanja i vještačenja "Ivan Vučetić"

Profili:

Avatar Url Filip Rokić (autor)

Avatar Url Marina Korolija (autor)

Avatar Url Lucija Barbarić (autor)

Poveznice na cjeloviti tekst rada:

doi link.springer.com doi.org

Citiraj ovu publikaciju:

Sukser, Viktorija; Rokić, Filip; Barbarić, Lucija; Korolija, Marina
Assessment of Illumina® Human mtDNA Genome assay: workflow evaluation with development of analysis and interpretation guidelines // International journal of legal medicine, 135 (2021), 1161-1178 doi:10.1007/s00414-021-02508-z (međunarodna recenzija, članak, znanstveni)
Sukser, V., Rokić, F., Barbarić, L. & Korolija, M. (2021) Assessment of Illumina® Human mtDNA Genome assay: workflow evaluation with development of analysis and interpretation guidelines. International journal of legal medicine, 135, 1161-1178 doi:10.1007/s00414-021-02508-z.
@article{article, author = {Sukser, Viktorija and Roki\'{c}, Filip and Barbari\'{c}, Lucija and Korolija, Marina}, year = {2021}, pages = {1161-1178}, DOI = {10.1007/s00414-021-02508-z}, keywords = {MiSeq, mitochondrial DNA, Nextera XT, evaluation, analysis thresholds}, journal = {International journal of legal medicine}, doi = {10.1007/s00414-021-02508-z}, volume = {135}, issn = {0937-9827}, title = {Assessment of Illumina® Human mtDNA Genome assay: workflow evaluation with development of analysis and interpretation guidelines}, keyword = {MiSeq, mitochondrial DNA, Nextera XT, evaluation, analysis thresholds} }
@article{article, author = {Sukser, Viktorija and Roki\'{c}, Filip and Barbari\'{c}, Lucija and Korolija, Marina}, year = {2021}, pages = {1161-1178}, DOI = {10.1007/s00414-021-02508-z}, keywords = {MiSeq, mitochondrial DNA, Nextera XT, evaluation, analysis thresholds}, journal = {International journal of legal medicine}, doi = {10.1007/s00414-021-02508-z}, volume = {135}, issn = {0937-9827}, title = {Assessment of Illumina® Human mtDNA Genome assay: workflow evaluation with development of analysis and interpretation guidelines}, keyword = {MiSeq, mitochondrial DNA, Nextera XT, evaluation, analysis thresholds} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font